Nexstim Receives FDA's Response to the Proposed Limited Size Stroke Trial Plan Medical Device Investing
Antares Pharma Announces Submission of New Drug Application for Quickshot® Testosterone Pharmaceutical Investing
Animas' OneTouch Vibe™ Plus Insulin Pump Earns FDA Approval and Health Canada License Medical Device Investing
Great Basin Scientific Submits 510(k) Application to the FDA for Stool Bacterial Pathogens Panel Medical Device Investing
Adamis Pharmaceuticals Announces NDA Resubmission of Its Epinephrine Pre-Filled Syringe Application to the FDA Pharmaceutical Investing
